The prognostic potential of the CCC-related biomarkers was validated in an external gene expression dataset (KM plotter) for OS of ovarian cancer patients (n = 655 for CCT5, KCTD10, and SETD3; n = 1,656 for the remaining CCC-related biomarkers). This evidence concerns the gene CCT5 and ovarian carcinoma.